Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/91157
DC FieldValueLanguage
dc.contributor.authorSimões, Marta F.-
dc.contributor.authorNogueira, Bernardo A.-
dc.contributor.authorTabanez, Andreia M.-
dc.contributor.authorRui Fausto-
dc.contributor.authorPinto, Rui M. A.-
dc.contributor.authorSimões, Sérgio-
dc.date.accessioned2020-10-10T12:43:12Z-
dc.date.available2020-10-10T12:43:12Z-
dc.date.issued2020-02-16-
dc.identifier.issn03785173pt
dc.identifier.urihttps://hdl.handle.net/10316/91157-
dc.description.abstractOne of the applications of Hot-Melt Extrusion (HME) is the stabilization of amorphous drugs through its incorporation into polymeric blends in the form of Amorphous Solid Dispersions (ASDs). In this study, HME was applied to solve a real problem in the development of an ibrutinib product, stabilizing the amorphous form. A systematic approach was followed by combining theoretical calculations, high-throughput screening (HTS) focused on physical stability and Principal Components Analysis (PCA). The HTS enabled the evaluation of 33 formulations for physical stability and the PCA was key to select four promising systems. The low relevance of drug loading on the drug crystallization supported the HME tests with a very high drug load of 50%. Milled extrudates were characterized and demonstrated to be fully amorphous. The thermal analysis detected a glass transition temperature much higher than the predicted values. Along with several weak intermolecular interactions detected in Raman spectroscopy, a dipolar interaction involving the α, β unsaturated ketone function of ibrutinib was also noticed. The additive effect of these intermolecular interactions changed markedly the performance of the ASDs. The physical strength of the prepared systems was corroborated by stability studies until 6 months at long-term and accelerated conditions.pt
dc.language.isoengpt
dc.publisherElsevierpt
dc.relationinfo:eu-repo/grantAgreement/FCT/PD/BDE/135149/2017/PTpt
dc.relationinfo:eu-repo/grantAgreement/FCT/UI0313/QUI/2013/PTpt
dc.rightsembargoedAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectAmorphous solid dispersionspt
dc.subjectHot-melt extrusionpt
dc.subjectIbrutinibpt
dc.subjectMultivariate statisticspt
dc.subjectPolymerspt
dc.subjectPrincipal components analysispt
dc.titleEnhanced solid-state stability of amorphous ibrutinib formulations prepared by hot-melt extrusionpt
dc.typearticle-
degois.publication.titleInternational Journal of Pharmaceuticspt
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S037851732030140Xpt
dc.peerreviewedyespt
dc.identifier.doi10.1016/j.ijpharm.2020.119156pt
degois.publication.volume579pt
dc.date.embargo2021-02-15*
uc.date.periodoEmbargo365pt
item.fulltextCom Texto completo-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextopen-
item.languageiso639-1en-
item.openairetypearticle-
item.cerifentitytypePublications-
crisitem.author.researchunitCQC - Coimbra Chemistry Centre-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.parentresearchunitFaculty of Sciences and Technology-
crisitem.author.orcid0000-0002-8264-6854-
crisitem.author.orcid0000-0003-2354-4177-
Appears in Collections:I&D CQC - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
Intl_J_Pharmaceut_579_2020_119156.pdf1.88 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons